Ipamorelin

Overview

Aurex Ipamorelin is a premium, selective growth hormone secretagogue (GHS) designed for precise research into pulsatile growth hormone (GH) release. As a pentapeptide and a Ghrelin mimetic, it offers a research tool focused on stimulating endogenous GH secretion with noted receptor selectivity.

Key Features & Benefits

• Selective GH Release: Research indicates a strong affinity for the ghrelin (GHSR-1a) receptor, primarily stimulating GH secretion without significant effect on cortisol, prolactin, or other pituitary hormones in experimental models.
• Natural Pulsatile Profile: Supports research aiming to mimic the body’s natural, episodic bursts of growth hormone, which is crucial for studying its downstream metabolic and regenerative effects.
• High-Quantity Research Format: The 10mg quantity is ideal for extended study protocols, dose-response curves, and repeated experiments requiring a consistent, high-purity source.
• High-Purity & Reliable: Each vial contains 10mg of Ipamorelin synthesized to ≥ 99% purity (HPLC verified), ensuring dependable and reproducible research outcomes.

Primary Research Applications

• Study of growth hormone pulsatility and its role in metabolism, body composition, and repair.
• Research into the selectivity of GHSR-1a receptor agonists and their specific endocrine profiles.
• Investigation of compounds that may influence muscle protein synthesis and lipolysis (fat breakdown).
• Used as a comparator or in combination with other peptides (e.g., CJC-1295) in synergistic research.

Product Specifications

• Unit Size: 10mg
• Compound: Ipamorelin
• Purity: ≥ 99% (HPLC verified)
• Quantity: 10mg per sterile lyophilized vial
• Form: Lyophilized (freeze-dried) powder
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Storage: Store in a cool, dry place. For long-term stability, refrigeration is recommended.

Important Notice

This product is for chemical and laboratory research purposes only. It is not for human or veterinary consumption. Ipamorelin is a potent peptide and should be handled by qualified researchers using appropriate safety procedures.